| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76ecc3d6efa6a63e6af98b58efc276af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6708801c2c60ab40e48bd661a96e11a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73345e025232a99a9e4fc27976cc6337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18f41feba1c141cc38d237219f7dd2aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f146242850b174b114cdb31f58fb922f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-06 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate |
2008-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35ea186b15fc4f168492a20d32e00e64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f2213c97b758e6f889a0e9e13ab647c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bf8e74369d3c0081cff942b57b95e6b |
| publicationDate |
2009-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009005870-A2 |
| titleOfInvention |
Products for prophylaxis and/or treatment of viral diseases and method of making and using same |
| abstract |
The invention relates to an immunoglobulin composition suitable for prophylaxis and/or treatment of a viral mediated disease, disorder or condition and to methods of its preparation. In one embodiment, the invention provides a potent intravenous immunoglobulin composition useful for the treatment or prevention of a West Nile virus mediated disease, disorder or condition. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014144511-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9556261-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9896501-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10738107-B2 |
| priorityDate |
2007-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |